Login / Signup
Similar 5-year HCC occurrence in Tenofovir- and Entecavir-treated HBV chronic infection in the French AFEF/ANRS CO22 Hepather cohort.
Stanislas Pol
null null
Published in:
Alimentary pharmacology & therapeutics (2021)
NCT019553458.
Keyphrases
</>
hepatitis b virus
risk assessment
liver failure
antiretroviral therapy
newly diagnosed
drug induced